Nuformix completes first stage of Magnus Life Science collaboration

Cambridge, UK - 11th February 2016

Following the commencement of Nuformix’s partnership with Magnus Life Science, Nuformix has successfully completed the first stage of its collaborative development plan.

Nuformix Chief Executive Officer, Dr Dan Gooding, said: “We’ve built an excellent working relationship with Magnus across the team, so I’m really happy that we were able to discover and develop a novel form of Magnus’ lead compound. We’re pleased to hand the reins back to Magnus and support them in the further development of this asset.”